Biofilm-Associated Infections in Chronic Wounds and Their Management

Area of Science:

• Wound healing and regenerative medicine
• Microbiology and infectious diseases
• Biomaterials and drug delivery

Background:

• Chronic wounds, including vascular, diabetic, and pressure ulcers, exhibit delayed healing.
• Prolonged inflammation, persistent infection, and antimicrobial-resistant biofilms characterize these wounds.
• Biofilm formation by opportunistic pathogens significantly impedes effective chronic wound management.

Purpose of the Study:

• To discuss the role of biofilms, particularly those formed by ESKAPE pathogens and Candida species, in delaying chronic wound healing.
• To review current and emerging techniques for biofilm detection in wound management.
• To deliberate on the limitations of existing therapeutics and explore novel wound management strategies.

Main Methods:

• Literature review focusing on biofilm formation in chronic wounds.
• Analysis of common pathogens involved in chronic wound biofilms, including ESKAPE group and Candida species.
• Examination of traditional and novel wound management techniques, with an emphasis on anti-biofilm strategies.

Main Results:

• Biofilms contribute to prolonged inflammation and resistance to antimicrobials and host immunity in chronic wounds.
• ESKAPE pathogens (Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa) and Candida species are key players in chronic wound biofilms.
• Novel anti-biofilm agents and advanced detection techniques show promise for improved wound healing.

Conclusions:

• Biofilm-associated infections are a critical challenge in chronic wound care.
• Effective chronic wound management requires strategies that target biofilm prevention, detection, and eradication.
• Emerging anti-biofilm therapies and diagnostic tools offer potential for enhanced wound healing outcomes.